Insmed Cash Provided by (Used in) Operating Activity, Including Discontinued Operation increased by 10.0% to -$222.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from -$262.09M to -$222.74M. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Operating Activity, Including Discontinued Operation shows a downward trend with a 26.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A comprehensive measure of the company's total cash generation efficiency.
The consolidated net cash flow from operating activities, including both continuing and discontinued operations. It prov...
Standard consolidated cash flow metric used by all global enterprises.
other_net_cash_provided_by_used_in_operating_activities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$75.44M | -$75.45M | -$84.13M | -$105.16M | -$102.30M | -$89.83M | -$103.15M | -$146.30M | -$122.79M | -$136.33M | -$130.82M | -$184.04M | -$122.95M | -$180.92M | -$195.98M | -$262.09M | -$205.57M | -$219.76M | -$247.60M | -$222.74M |
| QoQ Change | — | -0.0% | -11.5% | -25.0% | +2.7% | +12.2% | -14.8% | -41.8% | +16.1% | -11.0% | +4.0% | -40.7% | +33.2% | -47.1% | -8.3% | -33.7% | +21.6% | -6.9% | -12.7% | +10.0% |
| YoY Change | — | — | — | — | -35.6% | -19.1% | -22.6% | -39.1% | -20.0% | -51.8% | -26.8% | -25.8% | -0.1% | -32.7% | -49.8% | -42.4% | -67.2% | -21.5% | -26.3% | +15.0% |